Table 5 Subjects parameters changes
Variable | Tocotrienols (n = 30) | Placebo (n = 34) | PValue (Tocotrienols vs Placebo) |
|---|---|---|---|
BMI (kg/m2) | -0.6 | -0.3 | 0.527 |
TC (mmol/L) | -0.3 | -0.2 | 0.055 |
HDL (mmol/L) | -0.04 | 0.02 | 0.778 |
LDL (mmol/L) | -0.2 | -0.1 | 0.052 |
TG (mmol/L) | -0.2 | -0.2 | 0.814 |
ALP (IU/L) | -7.0 | 1.4 | 0.471 |
AST (IU/L) | -4.8 | -3.4 | 0.207 |
ALT (IU/L) | -5.9 | -0.6 | 0.118 |
GGT (IU/L) | -1.4 | -4.2 | 0.364 |
C-rp (mg/L) | -0.2 | -0.2 | 0.835 |
Apo B (g/L) | -0.01 | -0.03 | 0.046 |
Lp(A) (mg/dL) | 2.3 | 0.4 | 0.524 |
Serum creatinine (μmol/L) | -5.1 | -1.9 | 0.524 |
Fasting glucose (mmol/L) | 0.5 | 0.5 | 0.490 |
Systolic (mmHg) | 0.1 | 0.6 | 0.660 |
Diastolic (mmHg) | -0.3 | -2.4 | 0.607 |